Healthcare: How Marijuana Legalization Impacted OrganiGram and Aphria's Latest Results
Industry Focus
The Motley Fool
4.6 • 854 Ratings
🗓️ 17 April 2019
⏱️ 29 minutes
🧾️ Download transcript
Summary
Marijuana stocks OrganiGram and Aphria reported quarterly earnings this week - here's what you should know. Also, Abbott locks horns with DexCom in diabetes and what's next for Bristol-Myers' now that its Celgene acquisition is official.
Check out more of our content here:
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Thanks to LinkedIn for supporting industry focus. |
| 0:03.0 | LinkedIn jobs makes it easy to get matched with quality candidates who make the most sense for your role. |
| 0:08.5 | Post a job today at LinkedIn.com slash full and get $50 off your first job post. |
| 0:15.0 | Welcome to Industry Focus, the show that dives into a different sector of the stock market every single day. |
| 0:23.7 | Today is Wednesday, April the 17th, and we're talking health care. |
| 0:27.3 | I'm your host Shannon Jones. |
| 0:29.3 | And I am joined by health care guru Todd Campbell. |
| 0:32.1 | Todd, how are you? I'm doing well up here in |
| 0:35.6 | sunny New Hampshire happy to see that mud season hasn't yet arrived maybe we'll |
| 0:40.5 | skip it this year and go straight to summer. Hey, you never know and it seems like that's happening more and more frequently. |
| 0:46.0 | I think we'll probably hit 80-90 degrees here in the next couple of weeks in Alexandria. |
| 0:50.0 | Wow. Crazy. It is crazy, but for today's topic we've got some less crazier |
| 0:57.8 | updates to share with our listeners. Specifically we've got news from across the sector, including merger updates, |
| 1:05.9 | the Diabetes Stock Wars, and as always, marijuana earnings updates. |
| 1:11.3 | Todd, let's dive right in. |
| 1:13.3 | We promised our listeners that we would be following up on the soap opera that has been Selgin and |
| 1:19.8 | Bristol-Myersquib. |
| 1:20.8 | Of course, ticker symbols there. C-G and B-M-Y. Really, the new story here has been about the fate of this $74 billion merger, which came down to a shareholder meeting last week. |
| 1:35.0 | There's been just so much politicking on both sides of this debate and whether or not this deal should go through. |
| 1:42.0 | You had a lot of very vocal shareholders. and whether or not this deal should go through. |
| 1:42.5 | You had a lot of very vocal shareholders |
| 1:45.3 | saying that this was a deal that was very poorly |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.